Literature DB >> 6478426

The effect of estrogen, progesterone, thyroxine, and human placental lactogen on DNA synthesis of human breast ductal epithelium maintained in athymic nude mice.

M J McManus, C W Welsch.   

Abstract

Specimens of human breast tissues from the periphery of excised benign tumors, obtained from 17 pre-menopausal patients, were processed into slices and transplanted subcutaneously to 122 female Balb/c athymic nude mice. Subsequently, the host mice were treated with estrogens, progesterone, thyroxine, and human placental lactogen (HPL) alone or in combination. Growth of the ductal epithelium within the human breast transplants, as a function of the hormone treatment, was assessed by 3H-thymidine autoradiographic analysis, i.e., the number of 3H-thymidine radiolabeled ductal cells per unit area of ductal epithelium (labeling index [LI]). The administration of estrogen or thyroxine alone significantly increased the LI. Progesterone or HPL treatments alone did not substantially influence LI. HPL treatment, but not progesterone or thyroxine treatments significantly enhanced the stimulatory effect of estrogen on LI. The athymic nude mouse as host to human breast tissues in these in vivo/ex vivo studies, has been instrumental in producing information that effectively increases understanding of the hormonal factors influencing DNA synthesis in human breast ductal epithelium.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6478426     DOI: 10.1002/1097-0142(19841101)54:9<1920::aid-cncr2820540924>3.0.co;2-f

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  20 in total

Review 1.  Estrogen responsiveness and control of normal human breast proliferation.

Authors:  E Anderson; R B Clarke; A Howell
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-01       Impact factor: 2.673

Review 2.  Establishing a framework for the functional mammary gland: from endocrinology to morphology.

Authors:  Russell C Hovey; Josephine F Trott; Barbara K Vonderhaar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

3.  Influence of fetal bovine serum and hormones on primary vs. long-term cultures of human breast cancers.

Authors:  Y de Launoit; P Gasperin; O Pauwels; D Larsimont; S Gras; R Kiss
Journal:  In Vitro Cell Dev Biol       Date:  1991-03

4.  Proliferative and secretory activity in human breast during natural and artificial menstrual cycles.

Authors:  J J Going; T J Anderson; S Battersby; C C MacIntyre
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

Review 5.  Deciphering the divergent roles of progestogens in breast cancer.

Authors:  Jason S Carroll; Theresa E Hickey; Gerard A Tarulli; Michael Williams; Wayne D Tilley
Journal:  Nat Rev Cancer       Date:  2016-11-25       Impact factor: 60.716

6.  Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors.

Authors:  Monica Salazar; Alejandra Lerma-Ortiz; Grace M Hooks; Amanda K Ashley; Ryan L Ashley
Journal:  Gene       Date:  2016-06-24       Impact factor: 3.688

7.  Inter-Individual Variation in Response to Estrogen in Human Breast Explants.

Authors:  Karen A Dunphy; Amye L Black; Amy L Roberts; Aman Sharma; Zida Li; Sneha Suresh; Eva P Browne; Kathleen F Arcaro; Jennifer Ser-Dolansky; Carol Bigelow; Melissa A Troester; Sallie S Schneider; Grace Makari-Judson; Giovanna M Crisi; D Joseph Jerry
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-03-09       Impact factor: 2.673

8.  Proliferative and secretory activity in the pregnant and lactating human breast.

Authors:  S Battersby; T J Anderson
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

9.  Exercise and breast cancer prevention.

Authors:  Leslie Bernstein
Journal:  Curr Oncol Rep       Date:  2009-11       Impact factor: 5.075

Review 10.  Antiestrogen action of progesterone in breast tissue.

Authors:  P Mauvais-Jarvis; F Kuttenn; A Gompel
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.